Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
oleh: Kadidja Gamougam, Doumagoum M. Daugla, Jacques Toralta, Cyriaque Ngadoua, Florence Fermon, Anne-Laure Page, Mamoudou Djingarey, Dominique A. Caugant, Olivier Manigart, Caroline L. Trotter, James M. Stuart, Brian M. Greenwood
| Format: | Article |
|---|---|
| Diterbitkan: | Centers for Disease Control and Prevention 2015-01-01 |
Deskripsi
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.